Self-limited patients
n, )

Chronic HBV patients
n, )

OR

95 CI

P

MxA-88 alleles

G

201(62.8)

364(74.9)

0.57

0.42~0.77

0.001

T

119(37.2)

122(25.1)

MxA-88 genotypes

GG

66(41.3)

128(52.7)

0.63

0.42~0.94

0.025

GT

69(43.1)

108(44.4)

0.95

0.63~1.42

0.765

TT

25(15.6)

7(2.9)

6.24

2.63~14.81

0.001

MxA-123 alleles

C

262(81.9)

387(79.6)

1.15

0.81~1.66

0.380

A

58(18.1)

99(20.4)

MxA-123 genotypes

CC

110(68.7)

156(64.2)

1.23

0.80~1.88

0.346

CA

42(26.3)

75(30.9)

0.80

0.51~1.24

0.324

AA

8(5.0)

12(4.9)

1.01

0.40~2.54

0.990

elF-2α reg2 alleles

A

286(89.4)

417(85.8)

1.39

0.90~2.16

0.178

G

34(10.6)

69(14.2)

elF-2α reg2 genotypes

AA

130(81.3)

186(76.5)

1.33

0.81~2.18

0.259

AG

26(16.2)

45(18.5)

0.85

0.50~1.45

0.653

GG

4(2.5)

12(5.0)

0.49

0.16~1.56

0.241

Table 3: Comparisons of three polymorphisms between patients in self-limited and chronic HBV infection.